Modern and traditional trance language: a comparison.
Sarah KarraschJohanna Alisa JungSuchithra VaradarajanIris-Tatjana KolassaWalter BongartzPublished in: The American journal of clinical hypnosis (2022)
This study compares the effects of two trance texts using different language patterns, i.e., modern trance language (MTL) characterized by indirect suggestions as well as narrative style and traditional trance language (TTL) found in traditional societies (e.g., Navajo, San, Aranda aborigines, etc.) that uses multiple repetitions along with narrative sequences. The Phenomenology of Consciousness Inventory (PCI) was used to evaluate the effects of both texts regarding cognition, emotion, physical experience, and trance depth. In this randomized controlled online study, 178 participants were assigned either to the MTL group or to the TTL group. The PCI and other tests (e.g. Positive and Negative Affect Schedule, State-Trait-Anxiety Inventory) were presented to the participants before and after listening to the hypnosis audio of the respective trance text. There were no significant differences between groups concerning trance depth, emotional, and physical experience. However, on the cognitive-imaginative level it was shown that the TTL group experienced more imaginations (PCI-subdimension "visual imagery," p = .009, d = 0.38) and less cognitive activity (PCI-subdimension "inner dialogue," p = .002, d = 0.40) than the MTL group. The results indicate that TTL increases imagery and decreases cognitive activity to a larger extent than MTL. This further indicates the potential of TTL to facilitate more vivid and intensive trance experiences.
Keyphrases
- autism spectrum disorder
- percutaneous coronary intervention
- coronary artery disease
- acute myocardial infarction
- acute coronary syndrome
- mental health
- antiplatelet therapy
- st elevation myocardial infarction
- st segment elevation myocardial infarction
- atrial fibrillation
- physical activity
- coronary artery bypass grafting
- randomized controlled trial
- open label
- heart failure
- gene expression
- depressive symptoms
- clinical trial
- phase iii
- risk assessment
- white matter
- psychometric properties
- study protocol